论文部分内容阅读
上海抗癌药物咨询中心由上海市12个临床综合性医院参加的抗癌药物临床观察组组成,于1991年1月至1992年3月先后随机选择应用以阿霉素为主联合化疗方案,治疗恶性肿瘤患者293例,作近期疗效和毒性反应观察,报告如下。1 资料分析293例中、晚期恶性肿瘤患者,入院时均已明确诊断,其中275例有术后病理或脱落细胞检查阳性,18例根据胸片、B超、CT扫描诊断。男性189例,女性104例,男∶女=1.9∶1,年龄在34～80岁之间,平均年龄61.5岁。其中肺癌77例,胃癌61例,贲门癌28例,直结肠癌25例,肝癌16例,乳腺癌25
The Shanghai Anticancer Drugs Consultation Center consists of clinical observation teams of 12 anticancer drugs participated by 12 clinical general hospitals in Shanghai. From January 1991 to March 1992, they randomly selected doxorubicin as the main combined chemotherapy regimen. 293 patients with malignant tumors were observed for short-term efficacy and toxicity. The report is as follows. 1 Data analysis 293 patients with advanced and advanced malignant tumors were diagnosed on admission. Among them, 275 patients had positive postoperative pathological or exfoliative cells, and 18 patients were diagnosed by chest X-ray, B-ultrasonography, and CT scan. There were 189 males and 104 females, male: female = 1.9:1, aged between 34 and 80 years, and the average age was 61.5 years. Among them, there were 77 cases of lung cancer, 61 cases of gastric cancer, 28 cases of cardiac cancer, 25 cases of colorectal cancer, 16 cases of liver cancer, and 25 cases of breast cancer.